Spencer Knight: Breakthrough in Gene Therapy – Life-Changing Vision Restored for Young Girl
Spencer Knight, Business Development Director at Hartmann Young, shared a post on LinkedIn:
“Breakthrough in Gene Therapy: Life-Changing Vision Restored for Young Girl
Saffie Sandford, a six-year-old girl from Stevenage, was diagnosed with a rare inherited eye condition called Leber’s Congenital Amaurosis (LCA) – a disorder that can lead to complete blindness.
Without treatment, her family were told she could lose her sight by adulthood.
In a groundbreaking procedure at Great Ormond Street Hospital, doctors used a one-off gene therapy called Luxturna, injecting a healthy copy of the faulty gene directly into her eyes.
The results have been remarkable.
After struggling to see in low light for years, Saffie can now see in the dark something her family described as ‘like a magic wand.’
She’s now doing everyday things many take for granted, from playing outside at night to enjoying activities she once had to miss out on.
The treatment has significantly improved her vision and quality of life, especially because it was given at such a young age and highlights the power of gene therapy to transform lives of children with rare genetic conditions.
Incredible to see science making the impossible possible.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments